Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

11 March 2023: Database Analysis

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics

Yan-qi Kou 1ACEF* , Yu-ping Yang 1BCE* , Zhao-jie Pan 2E* , Shen-shen Du 1BC* , Wei-nan Yuan 1BC , Kun He 1E , Biao Nie 1A*

DOI: 10.12659/MSM.938785

Med Sci Monit 2023; 29:e938785

Table 1 Clinicopathologic characteristics of PDAC patients.

Gender, n (%)Female59 (47.2%)
Male66 (52.8%)
Tumor grade, n (%)G18 (6.4%)
G288 (70.4%)
G328 (22.4%)
G41 (0.8%)
Tumor stage, n (%)Stage I14 (11.2%)
Stage II64 (51.2%)
Stage III40 (32%)
Stage IV7 (5.6%)
Vital status, n (%)Alive43 (34.4%)
Dead82 (65.6%)
Recurrence status, n (%)No58 (46.4%)
Yes67 (53.6%)
Cancer status, n (%)Not reported17 (13.6%)
Tumor free30 (24%)
With tumor78 (62.4%)
Age, median (IQR)65 (60, 72)
OS, median (IQR)448 (256, 733)
RFS, median (IQR)348 (172, 579)

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750